β2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts

Kidney International

Volumn 53, Issue 5, 1998, Pages 1365-1373

  Owen Jr , William F ^a   Hou, Fan Fan ^b   Stuart, Robert O ^b   Kay, Jonathan ^b   Boyce, Joshua ^b   Chertow, Glenn M ^b   Schmidt, Ann Marie ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Advanced glycation end products; Amyloidosis; Collagen; Dialysis; Epidermal growth factor; Fibroblasts

Indexed keywords

BETA 2 MICROGLOBULIN; COLLAGEN TYPE 1; EPIDERMAL GROWTH FACTOR; GLYCOSYLATED PROTEIN; IMMUNOGLOBULIN G; MESSENGER RNA; PROCOLLAGEN; RECEPTOR ANTIBODY;

AMYLOIDOSIS; ARTICLE; BONE REMODELING; COLLAGEN SYNTHESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SKIN FIBROBLAST;

EID: 7344228965     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00882.x     Document Type: Article

References (38)

1. KAY J: Beta 2-microglobulin amyloidosis. Amyloid Int J Invest 4:187-211, 1997
2. DRUEKE T, TOUAM M, ZINGRAFF J: Dialysis-associated amyloidosis. Adv Renal Repl Ther 2:24-39, 1995
3. GEJYO F, HOMMA N, ARAKAWA M: Long-term complications of dialysis: Pathogenic factors with special reference to amyloidosis. Kidney Int 43(Suppl 41):S78-S82, 1993
4. MIYATA T, ODA O, INAGI R, IIDA Y, ARAKI N, YAMADA N: β2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92:1243-1252, 1993
5. SPRAGUE SM: Is β2-microglobulin a mediator of hone disease? Kidney Int 47:1-6, 1995
6. MIYATA T, INAGI R, IIDA Y, SATO M, YAMADA N, ODA O, MAEDA K, SEO H: Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. J Clin Invest 93:521-528, 1994
7. IIDA Y, MIYATA T, INAGI R, SUGIYAMA S, MAEDA K: Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: Role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophys Res Commun 201:1233-1241, 1994
8. MIYATA T, HORI O, ZHANG JH, YAN SD, FERRAN L, IIDA Y, SCHMIDT AM: The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-β2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. J Clin Invest 98:1088-1094, 1996
9. SCHMIDT AM, VIANNA M, GERLACH M, BRETT J, RYANJ, KAO J, ESPOSITO C, HEGARTY H, HURLEY W, CLAUSS M, WANG F, PAN YC, TSANG TC, STERN D: Isolation and characterization of binding proteins for advanced glycosylation end products from lung tissue which are present on the endothelial cell surface. J Biol Chem 267:14987-14997, 1992
10. NEEPER M, SCHMIDT AM, BRETT J, YAN SD, WANG F, PAN YC, ELLISTON K, STERN D, SHAW A: Cloning and expression of RAGE: A cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004, 1992
11. KIRSTEIN M, VAN DEVENTER S, VLASSARA H: Advanced glycosylation end product (AGE) binding to its specific receptor stimulates increase in EGF and EGF receptor mRNAs: Role in tissue remodeling, (abstract) J Cell Biochem 14E:76, 1990
12. VLASSARA H, BROWNLEE M, CERAMI A: High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: A potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci USA 82:5588-5592, 1985
13. HOU FF, CHERTOW GM, KAY J, BOYCE J, LAZARUS JM, BRAATZ JA OWEN WF JR: The interaction between β2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis. Kidney Int 51:1514-1519, 1997
14. ARAKI N, UENO N, CHAKRABARTI B, MORINO Y, HORIUCHI S: Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 267:10211-10214, 1992
15. SCHMIDT AM, YAN SD, BRETT J, MORA R, NOWYGROD R, STERN D: Regulation of human mononuclear phagocyte migration by cell surface-binding protein for advanced glycation end products. J Clin Invest 92:2155-2168, 1993
16. JOHNSON D, GAUTSCH J, SPORTSMAN J, ELDER J: Improved technique utilizing non-fat dry milk for analysis of proteins and nucleic acids transferred to nitrocellulose. Gene Anal Tech 1:3-8, 1984
17. CHOMCZYNSKI P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Bio Tech 15:532-537, 1993
18. COLIGE A, LAMBERT CA, NUSGENS BV, LAPIERE CM: Effect of cell-cell and cell-matrix interactions on the response of fibroblasts to epidermal growth factor in vitro. Biochem J 285:215-221, 1992
19. GIELEN JL, VAN HOLSBEECK MT, HAUGLUSTAINE D, VERRESEN L, VERBEKEN E, BAERT AL, MEEUS L, VANDEVOORDE P, MICHIOLSEN P, CORAL A: Growing bone cysts in long-term hemodialysis. Skei Radiol 19:43-49, 1990
20. BRINCKERHOFF CE, MTTCHELL TI, KARMILOWICZ MJ, KLUVE-BECKERMAN B, BENSON MD: Autocrine induction of collagenasc by serum amyloid A-like and β2-microglobulin-like proteins. Science 243:655-657, 1989
21. CANALIS E, MCCARTHY T, CENTRELLA M: A bone-derived growth factor isolated from rat is beta 2 microglobulin. Endocrinology 121: 1198-1200, 1987
22. EVANS DB, THAVARAJAN M, KANIS JA: Immunoreactivity and proliferative actions of β2-microglobulin on human bone-derived cells in vitro. Biochem Biophys Res Comm 175:795-803, 1991
23. JENNINGS JC, MOHAN S, BAYLINK DJ: β2-microglobulin is not a bone cell mitogen. Endocrinology 125:404-409, 1989
24. MOE SM, SPRAGUE SM: β2-microglobulin induces calcium efflux from cultured neonatal mouse calvariae. Am J Physiol 263:F540-F545, 1992
25. HOROWITZ MC: Cytokines and estrogen in bone: Anti-osteoporotic effects. Science 260:626-627, 1993
26. BERTOLINI DR, NEDWIN GE, BRINGMAN TS, SMITH DD, MUNDY GR: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature 319:516-518, 1986
27. EHLERDING G, FLOGE J, SCHAFFER J, DROMMER W, KOCH K: Immunohistological characterization of cells in the joint capsule of patients on long-term haemodialysis. (abstract) Nephrol Dial Transplant 8:986, 1993
28. ARGILES A, MOURAD G, KERR P, GARCIA M, COLLINS B, DEMAILLE J: Cells surrounding haemodialysis-associated amyloid deposits are mainly macrophages. Nephrol Dial Transplant 9:662-667, 1994
29. VLASSARA H: Protein glycation in the kidney: Role in diabetes and aging. Kidney Int 49:1795-1804, 1996
30. YANG Z, MAKITA Z, HORII Y, BRUNELLE S, CERAMI A, SEHAJPAL P, SUTHANTHIRAN M, VLASSARA H: Two novel rat liver membrane proteins that bind advanced glycosylation end products: Relationship to macrophage receptor for glucose-modified proteins. J Exp Med 174:515-524, 1991
31. VLASSARA H, LI YM, IMANI Y, WOJCIECHOWICZ D, YANG A, LIU FT: Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): A new member of the AGE-receptor complex. Mol Med 1:634-646, 1995
32. SCHMIDT AM, VIANNA M, GERLACH M, BRETT J, RYAN J, KAO J, ESPOSITO C, HEGARTY H, HURLEY W, CLAUSS M, WANG F, PAM Y-E, TSANG T-C, STERN D: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267:14987-14997, 1992
33. BRETT J, SCHMIDT AM, YAN SD, ZOU YS, WEIDMAN E, PINSKY D, NOWYGROD R, NEEPER M, PRZYSIECKI C, SHAW A, MIGHELI A, STERN D: Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissue. Am J Pathol 143:1699-1712, 1993
34. COLIGE AC, LAMBERT CA, NUSGENS BV, LAPIERE CM: Effect of cell-cell and cell-matrix interactions on the response of fibroblasts to epidermal growth factor in vitro. Biochem J 285:215-221, 1992
35. MARHAMATI DJ, SONENSHEIN GE: B-myb expression in vascular smooth muscle cells occurs in a cell cycle-dependent fashion and down-regulates promoter activity of type I collagen genes. J Biol Chem 271:3359-3365, 1996
36. BURGESON RE, NIMNI ME: Collagen types, molecular structure and tissue distribution. Clin Orthop 282:250-272, 1992
37. MIYATA T, TANEDA S, KAWAI R, UEDA Y, HORIUCHI S, HARA M, MAEDA K, MONNIER VM: Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93:2353-2358, 1996
38. ASSOUNGA AG, BASCOUL S, CANAUD B, BOUYA PA, VENDRELL JP, SCIOLLA JP, MOURAD G, BALDET P, SERRE A, MION C: A study of β2-microglobulin skin deposits in dialyzed patients and healthy controls. Am J Kidney Dis 6:556-561, 1990